Methods of administering antibodies that bind interleukin 13

Abstract

Described herein are methods of administration of antibodies that bind interleukin 13 (IL-13) and methods of use thereof. In certain aspects, described herein are methods of inhibiting IL-13 biological activity. In certain aspects, the antibodies and methods described herein are used for treatment of an inflammatory disorder or disease, such as atopic dermatitis.